SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-026996
Filing Date
2022-02-25
Accepted
2022-02-25 07:30:51
Documents
15
Period of Report
2022-02-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm227637d1_8k.htm   iXBRL 8-K 31288
2 EXHIBIT 1.1 tm227637d1_ex1-1.htm EX-1.1 288358
3 EXHIBIT 5.1 tm227637d1_ex5-1.htm EX-5.1 9910
7 GRAPHIC tm227637d1_ex5-1img001.jpg GRAPHIC 4935
  Complete submission text file 0001104659-22-026996.txt   582232

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ocgn-20220222.xsd EX-101.SCH 3042
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocgn-20220222_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocgn-20220222_pre.xml EX-101.PRE 22601
9 EXTRACTED XBRL INSTANCE DOCUMENT tm227637d1_8k_htm.xml XML 3481
Mailing Address 263 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 263 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 22674419
SIC: 2836 Biological Products, (No Diagnostic Substances)